Guizhi-Shaoyao-Zhimu decoction attenuates bone erosion in rats that have collagen-induced arthritis via modulating NF‐κB signalling to suppress osteoclastogenesis

References

• Adamopoulos IE, Chao CC, Geissler R, Laface D, Blumenschein W, Iwakura Y, McClanahan T, Bowman EP. 2010. Interleukin-17A upregulates receptor activator of NF-kappaB on osteoclast precursors. Arthritis Res Ther. 12(1):R29.
   PubMed Web of Science ®Google Scholar
• Aletaha D, Smolen JS. 2018. Diagnosis and management of rheumatoid arthritis: a review. JAMA. 320(13):1360–1372.
   PubMed Web of Science ®Google Scholar
• Atkins G, Kostakis P, Vincent C, Farrugia AN, Houchins JP, Findlay DM, Evdokiou A, Zannettino AC. 2006. RANK expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow, and giant cell tumors of bone. J Bone Miner Res. 21(9):1339–1349.
   PubMed Web of Science ®Google Scholar
• Boyce BF. 2013. Advances in the regulation of osteoclasts and osteoclast functions. J Dent Res. 92(10):860–867.
   PubMed Web of Science ®Google Scholar
• Brand DD, Latham KA, Rosloniec EF. 2007. Collagen-induced arthritis. Nat Protoc. 2(5):1269–1275.
   PubMed Web of Science ®Google Scholar
• Brennan FM, McInnes IB. 2008. Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest. 118(11):3537–3545.
   PubMed Web of Science ®Google Scholar
• Bridges SL Jr, White DW, Worthing AB, Gravallese EM, O'Dell JR, Nola K, Kay J, Cohen SB. 2018. The science behind biosimilars: entering a new era of biologic therapy. Arthritis Rheumatol. 70(3):334–344.
   PubMed Web of Science ®Google Scholar
• Brzustewicz E, Bryl E. 2015. The role of cytokines in the pathogenesis of rheumatoid arthritis—practical and potential application of cytokines as biomarkers and targets of personalized therapy. Cytokine. 76(2):527–536.
   PubMed Web of Science ®Google Scholar
• Chambers TJ. 2000. Regulation of the differentiation and function of osteoclasts. J Pathol. 192(1):4–13.
   PubMed Web of Science ®Google Scholar
• Chen Z, Li XP, Li ZJ, Xu L, Li XM. 2013. Reduced hepatotoxicity by total glucosides of paeony in combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis. Int Immunopharmacol. 15(3):474–477.
   PubMed Web of Science ®Google Scholar
• Chingcuanco F, Segal JB, Kim SC, Alexander GC. 2016. Bioequivalence of biosimilar tumor necrosis factor-α inhibitors compared with their reference biologics: a systematic review. Ann Intern Med. 165(8):565–574.
   PubMed Web of Science ®Google Scholar
• Cross M, Smith E, Hoy D, Carmona L, Wolfe F, Vos T, Williams B, Gabriel S, Lassere M, Johns N, et al. 2014. The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 73(7):1316–1322.
   PubMed Web of Science ®Google Scholar
• Daily JW, Zhang T, Cao S, Park S. 2017. Efficacy and safety of GuiZhi-ShaoYao-ZhiMu decoction for treating rheumatoid arthritis: a systematic review and meta-analysis of randomized clinical trials. J Altern Complement Med. 23(10):756–770.
   PubMed Web of Science ®Google Scholar
• Dekkers JS, Schoones JW, Huizinga TW, Toes RE, van der Helm-van Mil AH. 2017. Possibilities for preventive treatment in rheumatoid arthritis? Lessons from experimental animal models of arthritis: a systematic literature review and meta-analysis. Ann Rheum Dis. 76(2):458–467.
   PubMed Web of Science ®Google Scholar
• Edwards JR, Weivoda MM. 2012. Osteoclasts: malefactors of disease and targets for treatment. Discov Med. 13(70):201–210.
   PubMed Web of Science ®Google Scholar
• Fardellone P, Sejourne A, Paccou J, Goeb V. 2014. Bone remodelling markers in rheumatoid arthritis. Mediators Inflamm. 2014:484280.
   PubMed Web of Science ®Google Scholar
• Gravallese EM. 2003. Osteopontin: a bridge between bone and the immune system. J Clin Invest. 112(2):147–149.
   PubMed Web of Science ®Google Scholar
• Gravallese EM, Manning C, Tsay A, Naito A, Pan C, Amento E, Goldring SR. 2000. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum. 43(2):250–258.
   PubMed Web of Science ®Google Scholar
• Guo Q, Mao X, Zhang Y, Meng S, Xi Y, Ding Y, Zhang X, Dai Y, Liu X, Wang C, et al. 2016. Guizhi-Shaoyao-Zhimu decoction attenuates rheumatoid arthritis partially by reversing inflammation–immune system imbalance. J Transl Med. 14(1):165–165.
   PubMed Web of Science ®Google Scholar
• Huang RY, Pan HD, Wu JQ, Zhou H, Li ZG, Qiu P, Zhou YY, Chen XM, Xie ZX, Xiao Y, et al. 2019. Comparison of combination therapy with methotrexate and sinomenine or leflunomide for active rheumatoid arthritis: a randomized controlled clinical trial. Phytomedicine. 57:403–410.
   PubMed Web of Science ®Google Scholar
• Jia XY, Chang Y, Sun XJ, Wu HX, Wang C, Xu HM, Zhang L, Zhang LL, Zheng YQ, Song LH, et al. 2014. Total glucosides of paeony inhibit the proliferation of fibroblast-like synoviocytes through the regulation of G proteins in rats with collagen-induced arthritis. Int Immunopharmacol. 18(1):1–6.
   PubMed Web of Science ®Google Scholar
• Jin S, Hsieh E, Peng L, Yu C, Wang Y, Wu C, Wang Q, Li M, Zeng X. 2018. Incidence of fractures among patients with rheumatoid arthritis: a systematic review and meta-analysis. Osteoporos Int. 29(6):1263–1275.
   PubMed Web of Science ®Google Scholar
• Kim JH, Jin HM, Kim K, Song I, Youn BU, Matsuo K, Kim N. 2009. The mechanism of osteoclast differentiation induced by IL-1. J Immunol. 183(3):1862–1870.
   PubMed Web of Science ®Google Scholar
• Komatsu N, Takayanagi H. 2015. Arthritogenic T cells in autoimmune arthritis. Int J Biochem Cell Biol. 58:92–96.
   PubMed Web of Science ®Google Scholar
• Liu W, Zhang Y, Zhu W, Ma C, Ruan J, Long H, Wang Y. 2018. Sinomenine inhibits the progression of rheumatoid arthritis by regulating the secretion of inflammatory cytokines and monocyte/macrophage subsets. Front Immunol. 9:2228.
   PubMed Web of Science ®Google Scholar
• McInnes IB, Buckley CD, Isaacs JD. 2016. Cytokines in rheumatoid arthritis – shaping the immunological landscape. Nat Rev Rheumatol. 12(1):63–68.
   PubMed Web of Science ®Google Scholar
• Nakae S, Nambu A, Sudo K, Iwakura Y. 2003. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol. 171(11):6173–6177.
   PubMed Web of Science ®Google Scholar
• Papadaki M, Rinotas V, Violitzi F, Thireou T, Panayotou G, Samiotaki M, Douni E. 2019. New insights for RANKL as a proinflammatory modulator in modeled inflammatory arthritis. Front Immunol. 10:97–97.
   PubMed Web of Science ®Google Scholar
• Qin Y, Zeng HR, Wang L, Ran Q, Peng W, Gao YX, Huang QW, Tan J. 2019. Spectrum–effect relationship between HPLC fingerprint and free radicals scavenging in Guizhi Shaoyao Zhimu Decoction. Zhongguo Zhong Yao Za Zhi. 44(14):3042–3048.
   PubMedGoogle Scholar
• Redlich K, Smolen JS. 2012. Inflammatory bone loss: pathogenesis and therapeutic intervention. Nat Rev Drug Discov. 11(3):234–250.
   PubMed Web of Science ®Google Scholar
• Scott DL, Wolfe F, Huizinga TW. 2010. Rheumatoid arthritis. Lancet. 376(9746):1094–1108.
   PubMed Web of Science ®Google Scholar
• Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, et al. 1997. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 89(2):309–319.
   PubMed Web of Science ®Google Scholar
• Singh JA, Saag KG, Bridges SL Jr, Ak EA, Bannuru RR, Sullivan MC, Vaysbrot E, McNaughton C, Osani M, Shmerling RH, et al. 2016. 2015 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol. 68(1):1–26.
   PubMed Web of Science ®Google Scholar
• Sinigaglia L, Varenna M, Girasole G, Bianchi G. 2006. Epidemiology of osteoporosis in rheumatic diseases. Rheum Dis Clin North Am. 32(4):631–658.
   PubMed Web of Science ®Google Scholar
• Smolen JS, Landewe R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, Nam J, Ramiro S, Voshaar M, van Vollenhoven R, et al. 2017. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis. 76(6):960–977.
   PubMed Web of Science ®Google Scholar
• Sparks JA. 2019. Rheumatoid arthritis. Ann Intern Med. 170(1):ITC1–ITC16.
   PubMed Web of Science ®Google Scholar
• Tsuboi H, Matsui Y, Hayashida K, Yamane S, Maeda-Tanimura M, Nampei A, Hashimoto J, Suzuki R, Yoshikawa H, Ochi T. 2003. Tartrate resistant acid phosphatase (TRAP) positive cells in rheumatoid synovium may induce the destruction of articular cartilage. Ann Rheum Dis. 62(3):196–203.
   PubMed Web of Science ®Google Scholar
• Vanderborght A, Linsen L, Thewissen M, Geusens P, Raus J, Stinissen P. 2004. Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand mRNA expression in patients with rheumatoid arthritis and healthy controls. J Rheumatol. 31(8):1483–1490.
   PubMed Web of Science ®Google Scholar
• Walsh MC, Choi Y. 2014. Biology of the RANKL–RANK–OPG system in immunity, bone, and beyond. Front Immunol. 5:511.
   PubMed Web of Science ®Google Scholar
• Walsh NC, Gravallese EM. 2010. Bone remodeling in rheumatic disease: a question of balance. Immunol Rev. 233(1):301–312.
   PubMedGoogle Scholar
• Wang M, Huang J, Fan H, He D, Zhao S, Shu Y, Li H, Liu L, Lu S, Xiao C, et al. 2018. Treatment of rheumatoid arthritis using combination of methotrexate and Tripterygium glycosides tablets—a quantitative plasma pharmacochemical and pseudotargeted metabolomic approach. Front Pharmacol. 9:1051.
   PubMed Web of Science ®Google Scholar
• Wu M, Wang Y, Deng L, Chen W, Li YP. 2012. TRAF family member-associated NF-κB activator (TANK) induced by RANKL negatively regulates osteoclasts survival and function. Int J Biol Sci. 8(10):1398–1407.
   PubMed Web of Science ®Google Scholar
• Xiang N, Li XM, Zhang MJ, Zhao DB, Zhu P, Zuo XX, Yang M, Su Y, Li ZG, Chen Z, et al. 2015. Total glucosides of paeony can reduce the hepatotoxicity caused by methotrexate and leflunomide combination treatment of active rheumatoid arthritis. Int Immunopharmacol. 28(1):802–807.
   PubMed Web of Science ®Google Scholar
• Xu S, Wang Y, Lu J, Xu J. 2012. Osteoprotegerin and RANKL in the pathogenesis of rheumatoid arthritis-induced osteoporosis. Rheumatol Int. 32(11):3397–3403.
   PubMed Web of Science ®Google Scholar
• Yang CL, Or TC, Ho MH, Lau AS. 2013. Scientific basis of botanical medicine as alternative remedies for rheumatoid arthritis. Clin Rev Allergy Immunol. 44(3):284–300.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Peng W, Wei S, Wei D, Li R, Liu J, Peng L, Yang S, Gao Y, Wu C, et al. 2019. Guizhi-Shaoyao-Zhimu decoction possesses anti-arthritic effects on type II collagen-induced arthritis in rats via suppression of inflammatory reactions, inhibition of invasion & migration and induction of apoptosis in synovial fibroblasts. Biomed Pharmacother. 118:109367.
   PubMed Web of Science ®Google Scholar